Next Article in Journal
Business Risk Mitigation in the Development Process of New Monoclonal Antibody Drug Conjugates for Cancer Treatment
Previous Article in Journal
Development of a Minimalistic Physiologically Based Pharmacokinetic (mPBPK) Model for the Preclinical Development of Spectinamide Antibiotics
Previous Article in Special Issue
Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application
 
 
Review

Article Versions Notes

Pharmaceutics 2023, 15(6), 1760; https://doi.org/10.3390/pharmaceutics15061760
Action Date Notes Link
article xml file uploaded 18 June 2023 09:34 CEST Original file -
article xml uploaded. 18 June 2023 09:34 CEST Update -
article pdf uploaded. 18 June 2023 09:34 CEST Version of Record -
article html file updated 18 June 2023 09:35 CEST Original file -
article xml file uploaded 18 June 2023 10:29 CEST Update -
article xml uploaded. 18 June 2023 10:29 CEST Update https://www.mdpi.com/1999-4923/15/6/1760/xml
article pdf uploaded. 18 June 2023 10:29 CEST Updated version of record https://www.mdpi.com/1999-4923/15/6/1760/pdf
article html file updated 18 June 2023 10:30 CEST Update -
article html file updated 6 July 2023 20:34 CEST Update https://www.mdpi.com/1999-4923/15/6/1760/html
Back to TopTop